Stephen G Ellis MD

Adult Congenital Heart Disease, Interventional Cardiology

Professor of Medicine Section Head/Interventioanl Cardiology Cleveland Clinic

9500 Euclid AveCleveland, OH 44195
Phone+1 216-445-6712
Fax+1 216-445-6714

Dr. Ellis is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ellis' full profile Already have an account?

Education & Training

Emory University School of MedicineFellowship, Cardiovascular Disease, 1985 - 1986
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1982 - 1985
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1981 - 1982
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1978 - 1981
David Geffen School of Medicine at UCLAClass of 1978

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2002 - 2028
OH State Medical License 1991 - 2027
NY State Medical License 2002 - 2020
IL State Medical License 2002 - 2017
PA State Medical License 2002 - 2016
MI State Medical License 1986 - 1993
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017

Clinical Trials

A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction
COMPLETED
PHASE1, PHASE2
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis
COMPLETED
PHASE2, PHASE3
TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent
COMPLETED
PHASE2, PHASE3

Publications & Presentations

PubMed

1 citations
Coronary artery disease burden in kidney transplant candidates: Risk factors, outcomes, and impact on transplant eligibility.
Roger R Godinho, José Jayme Galvão de Lima, Carlos M Campos, Luís Henrique Wolff Gowdak, Henrique B Ribeiro
Cardiovascular Revascularization Medicine. 2026-04-01
Predicting LVEF After PCI and its Effect on Clinical Outcomes in Patients With Stable Ischemic Cardiomyopathy and LVEF≤50.
Stephen G Ellis, Ben Alencherry, Khaled Ziada, Jacqueline Tamis-Holland, Evan Whitehead
The American Journal of Cardiology. 2026-01-15
The New Clinical Interface: Information Retrieval and Reasoning With LLMs.
Mohamad Alkhouli, Stephen G Ellis
JACC. Cardiovascular Interventions. 2025-10-27

Abstracts/Posters

[Board 005] Ethnic Differences in 10 Year Clinical Outcomes After Drug Eluting Stenting: Why Do African Americans Fare So Poorly?
Stephen Ellis, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/16/2019

Press Mentions

ABSORB III: 5-Year Results Offer Renewed Hope for Bioresorbable StentsSeptember 26th, 2019
EuroCTO CASTLE: Prediction Model for CTO PCI Success Shows Good Discriminating AbilityFebruary 4th, 2019
Revascularization for Silent Ischemia Linked to Better OutcomesJanuary 17th, 2019